Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...

Outfit? Check. Glassy skin? Check. Glam life as a bridal stylist with a quarter of a million TikTok followers? Check. In so ...

Learn about SYNT-101, the emerging treatment for obesity that combines the best of two proven methods.

Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...

Losing weight after a years-long struggle, this letter writer gave credit to the method — then came the judgmental comments.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Among patients with diabetes who underwent PCI after an acute heart attack, those taking a GLP-1 had better survival rates ...

Discover How FuturHealth’s Affordable Semaglutide Subscription Program Helps Users Lose Weight Without Insurance, ...

Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being ...

Aide to RFK Jr. says White House is pushing for global price parity on GLP-1 drugs for weight loss. Read more here.